Consistent with this, analysis of independent datasets indicates that VAPB transcript levels are higher in primary prostate tumors than in benign or normal prostate tissues (as evidenced by TCGA data), supporting the idea that VAPB is indeed upregulated in prostate cancer. Here, VAPB is linked to prostate carcinoma.